ARCHIVES

Pretreatment with Azacitidine Achieves 28-Month Remission

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

Experts Call For Large International Study Of Mammography Screening In Ages 40-42

October 15, 1993

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975